课题基金 / 基金详情

The roles of cytokines in the development of autoimmune deseases

The roles of cytokines in the development of autoimmune deseases
细胞因子在自身免疫性疾病发展中的作用
批准号:
19059006
负责人:
IWAKURA Yoichiro
金额:
$32.26万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research on Priority Areas
财政年份:
2007
资助国家:
日本
项目状态:
已结题
起止时间:
2007 至 2009

项目摘要

项目成果

IWAKURA Yoichiro的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Rheumatoid arthritis (RA) is one of the most serious medical problems worldwide with approximately 1% of the people in the world affected. The disease is autoimmune in nature and characterized by chronic inflammation of the synovial tissues in multiple joints. High levels of inflammatory cytokine expression in the joints are characteristics of the disease, although the pathogenesis has not been elucidated completely. We have been studying the pathogenesis of the disease using two arthritis models that we originally developed ; HTLV-I transgenic (HTLV-I Tg) mice and IL-1 receptor antagonist-deficient (IL-1Ra KO) mice. In this study, we analyzed the roles of IL-17 family cytokines in the development of autoimmune diseases and the mechanisms of Th17 induction through DC activation. We found that 1) IL-17A, but not IL-17F, plays an important role in the development of autoimmune diseases and inflammatory diseases, 2) Both IL-17A and IL-17F play important roles in the host defense against bacterial infections, 3) Both Dectin-1 and Dectin-2, which is a receptor for β-glucans and α-mannans, respectively, on DCs, induce Th17 differentiation through activation of DCs, and play important role in the host defense against fungal infections. These findings should be of use for the development of new therapeutics against autoimmune diseases and fungal infection.
期刊论文(209)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1038/ni.1736
发表时间: 2009-06
期刊: Nature immunology
影响因子: 30.5
作者: []
通讯作者:
A C-type lectin that involved in the host defense against fungi plays an important role in the development of autoimmune arthritis
参与宿主防御真菌的 C 型凝集素在自身免疫性关节炎的发展中发挥重要作用
DOI: --
发表时间: 2008
期刊:
影响因子: --
作者: [inushi M, Sato M, Kanamoto A, Itoh A, Nagai S, Koyasu S, Dranoff G, and Tahara H, 服部浩一, Shinobu Saijo]
通讯作者: Shinobu Saijo
DOI: 10.4049/jimmunol.178.11.7385
发表时间: 2007-06-01
期刊: JOURNAL OF IMMUNOLOGY
影响因子: 4.4
作者: [Hayashi, Takahito, Ishida, Yuko, Kondo, Toshikazu]
通讯作者: Kondo, Toshikazu
DOI: 10.4049/jimmunol.180.6.4067
发表时间: 2008-03-15
期刊: JOURNAL OF IMMUNOLOGY
影响因子: 4.4
作者: [Nakamura, Kiwamu, Miyazato, Akiko, Kawakami, Kazuyoshi]
通讯作者: Kawakami, Kazuyoshi
158
    Establishment of an IL-1-related gene-manipulated mice library, aiming at uncovering pathophysiology of disease from a view point of systems biology
    • 批准号:
      20220009
    • 项目类别:
      Grant-in-Aid for Scientific Research (S)
    • 资助金额:
      $64.98万
    • 财政年份:
      2008
    • 负责人:
      IWAKURA Yoichiro
    • 依托单位:
    The roles of cytokines on the development of rheumatoid arthritis
    • 批准号:
      12470076
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $9.02万
    • 财政年份:
      2000
    • 负责人:
      IWAKURA Yoichiro
    • 依托单位:
    Development of rheumatoid arthritis models using transgenic technique
    • 批准号:
      10558120
    • 项目类别:
      Grant-in-Aid for Scientific Research (B).
    • 资助金额:
      $8.38万
    • 财政年份:
      1998
    • 负责人:
      IWAKURA Yoichiro
    • 依托单位:
    Pathogenesis of inflammatory arthropathy developed in HTLV-I transgenic mice
    • 批准号:
      04454198
    • 项目类别:
      Grant-in-Aid for General Scientific Research (B)
    • 资助金额:
      $4.16万
    • 财政年份:
      1992
    • 负责人:
      IWAKURA Yoichiro
    • 依托单位:
    国内基金
    海外基金
    KIF4A通过激活IL-17/NF-κB信号通路促进三阴性乳腺癌恶性进展的机制研究
    基于PI3K/AKT/Th17/IL-17调控炎症微环境探讨肺复方改善肺癌免疫治疗应答的临床及机制研究
    SPP1⁺巨噬细胞通过IL-8-EMT样转化-IL-17环路与滑膜成纤维细胞互作驱动类风湿关节炎难治性表型的机制研究
    • 批准号:
      2026JJ50588
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      李芬
    • 依托单位:
    IL-17失衡通过衰老T细胞来源的淋巴毒素驱动肾脏异位淋巴组织慢性炎症的机制
    • 批准号:
      JCZRLH202600547
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
    • 依托单位: